Tag: amyotropic lateral sclerosis
FDA Approves Controversial ALS Drug – Relyvrio
A close look a the FDA approval of Relyvrio.
Paralyzed Patient Communicates with Brain Implant
Brain-machine interfaces continue to advance.
Crowdfunding unproven stem cell treatments: overstated efficacy, unstated risks
Crowdfunding campaigns for unproven stem cell treatments exaggerate the benefits and underemphasize the risks, all the while raising considerable funds and generating social media buzz.
Communicating with the Locked In (update)
Researchers have made an incremental advance in using imaging and computers to communicate with patients who are completely locked-in. Let's review the state of this technology.
The perils and pitfalls of “patient-driven” clinical research
Dying of cancer can be a horrible way to go, but as a cancer specialist I sometimes forget that there are diseases that are equally, if not more, horrible. One that always comes to mind is amyotropic lateral sclerosis (ALS), more commonly known as Lou Gehrig’s disease. It is a motor neuron disease whose clinical course is characterized by progressive weakness, muscle...
Lithium for ALS – Angioplasty for MS
Peter Lipson reported Monday about new research suggesting that multiple sclerosis may be caused by venous blockage. He correctly characterized some of the hype surrounding this story as “irrational exuberance.” This is a phenomenon all too common in the media – taking the preliminary research of an individual or group (always presented as a maverick) and declaring it a “stunning breakthrough,” combined...